Altre lingue CalciMedica, Inc.

Azioni

CALC

US38942Q2021

Prezzo di chiusura Nasdaq Altri mercati azionari 00:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
5,6 ^USD	-0,88%		-2,44%	+95,80%

24/04	Calcimedica Inc. annuncia l'arruolamento dell'ultimo paziente nello studio Carpo di Fase 2B di Auxora? nella pancreatite acuta	CI
01/04	I principali ribassisti del pre-mercato	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis	25/04
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis	24/04
Calcimedica Inc. Announces Last Patient Enrolled in Phase 2B Carpo Trial of Auxora? in Acute Pancreatitis	24/04
Top Premarket Decliners	01/04
CalciMedica : Material Event - Form 8-K	29/03
CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	13/03
CalciMedica Inc. Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International Acute Kidney Injury At the 29th International Aki & CRRT Conference	13/03
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI and CRRT Conference	29/02
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference	29/02
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury	14/02
CalciMedica Gets FDA Nod for Phase 2 Trial of Acute Kidney Injury With Respiratory Failure Treatment	13/02
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury	13/02
Calcimedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora? for the Treatment of Severe Acute Kidney Injury	13/02
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02
CalciMedica, Inc. announced that it has received $20.252897 million in funding	05/02
Calcimedica Insider Bought Shares Worth $2,515,080, According to a Recent SEC Filing	26/01
CalciMedica Secures $55 Million Funding Deal With Investors; Shares Gain	22/01
CalciMedica Announces Private Placement of up to Approximately $55 Million	22/01
CalciMedica, Inc. announced that it expects to receive $20.4 million in funding	19/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CalciMedica, Inc.

Azioni

CALC

US38942Q2021

Altre lingue

Filtri